Molecular assessment of sentinel lymph node in breast cancer management

Histopathology

Volumn 55, Issue 1, 2009, Pages 107-113

  Douglas Jones, Anthony G ^a   Woods, Victoria ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Breast; Intraoperative diagnosis; Polymerase chain reaction; Sentinel lymph node

Indexed keywords

CYTOKERATIN; MAMMAGLOBIN;

AXILLARY LYMPH NODE; BREAST CANCER; BREAST METASTASIS; CANCER SURGERY; CLINICAL ASSESSMENT; HISTOPATHOLOGY; HUMAN; LYMPH NODE BIOPSY; LYMPHOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENTINEL LYMPH NODE; TUMOR CELL;

BREAST NEOPLASMS; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; KERATIN-19; LYMPH NODES; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE BIOPSY; UTEROGLOBIN;

EID: 68049145109     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.03218.x     Document Type: Review

References (54)

1. Morton DL, Wen DR, Foshag LJ, Essner R, Cochran A. Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck. J. Clin. Oncol. 1993 11 1751 1756.
2. Morton DL, Wen DR, Wong JH et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg. 1992 127 392 399.
3. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977 39 456 466.
4. den Bakker MA, van Weeszenberg A, de Kanter AY et al. Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance. J. Clin. Pathol. 2002 55 932 935.
5. Dixon M. Sentinel node biopsy in breast cancer. A promising technique, but it should not be introduced without proper trials. BMJ (Clinical Research Ed) 1998 317 295 296.
6. Veronesi U, Paganelli G, Galimberti V et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997 349 1864 1867.
7. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg. Oncol. 1993 2 335 339.
8. Kargozaran H, Shah M, Li Y et al. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy. J. Surg. Res. 2007 143 126 129.
9. Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann. Surg. 1997 226 271 276. discussion 276-278.
10. Mansfield L, Sosa I, Dionello R, Subramanian A, Devalia H, Mokbel K. Current management of the axilla in patients with clinically node-negative breast cancer: a nationwide survey of United Kingdom breast surgeons. Int. Semin. Surg. Oncol. 2007 4 4.
11. Sobin LH. UICC TNM classification of malignant tumours, 6th edn. Chichester : John Wiley & Sons, 2002.
12. van Diest PJ. Histopathological workup of sentinel lymph nodes: how much is enough? J. Clin. Pathol. 1999 52 871 873.
13. Greene FLPD, Fleming ID. AJCC cancer staging handbook - TMN classification of malignant tumours, 6th edn. New York : Springer, 2002.
14. Cserni G. Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up. J. Clin. Pathol. 1999 52 922 924. (Pubitemid 30005368)
15. Cserni G, Amendoeira I, Apostolikas N et al. Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. J. Clin. Pathol. 2004 57 695 701.
16. Cserni G, Gregori D, Merletti F et al. Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br. J. Surg. 2004 91 1245 1252. (Pubitemid 39331448)
17. Viale G, Maiorano E, Pruneri G et al. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann. Surg. 2005 241 319 325.
18. Weaver DL. Sentinel lymph nodes and breast carcinoma: which micrometastases are clinically significant? Am. J. Surg. Pathol. 2003 27 842 845.
19. Klevesath MB, Bobrow LG, Pinder SE, Purushotham AD. The value of immunohistochemistry in sentinel lymph node histopathology in breast cancer. Br. J. Cancer 2005 92 2201 2205.
20. Ellis IOPS, Bobrow L, Buley ID et al. Pathology reporting of breast disease. Sheffield : NHSBSP Publication No 58, 2005 16 18.
21. Weaver DL. Pathological evaluation of sentinel lymph nodes in breast cancer: a practical academic perspective from America. Histopathology 2005 46 702 706.
22. Cserni G. Evaluation of sentinel lymph nodes in breast cancer. Histopathology 2005 46 697 702.
23. Lyman GH, Giuliano AE, Somerfield MR et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J. Clin. Oncol. 2005 23 7703 7720.
24. Nathanson SD, Burke M, Slater R, Kapke A. Preoperative identification of the sentinel lymph node in breast cancer. Ann. Surg. Oncol. 2007 14 3102 3110.
25. Memarsadeghi M, Riedl CC, Kaneider A et al. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging. Radiology 2006 241 367 377.
26. Van Diest PJ, Torrenga H, Borgstein PJ et al. Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology 1999 35 14 18.
27. Karsten U, Stosiek P. Fast and sensitive immunodetection of carcinoma cells in sentinel nodes. Virchows Arch. 2002 440 325 329.
28. Salem AA, Douglas-Jones AG, Sweetland HM, Newcombe RG, Mansel RE. Evaluation of axillary lymph nodes using touch imprint cytology and immunohistochemistry. British J. Surg. 2002 89 1386 1389.
29. Aihara T, Munakata S, Morino H, Takatsuka Y. Comparison of frozen section and touch imprint cytology for evaluation of sentinel lymph node metastasis in breast cancer. Ann. Surg. Oncol. 2004 11 747 750.
30. Goyal A, Newcombe RG, Mansel RE. Clinical relevance of multiple sentinel nodes in patients with breast cancer. British J. Surg. 2005 92 438 442.
31. Viale G, Bosari S, Mazzarol G et al. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer 1999 85 2433 2438.
32. Veronesi U, Paganelli G, Viale G et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J. Natl. Cancer Instit. 1999 91 368 373.
33. Schoenfeld A, Luqmani Y, Smith D et al. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res. 1994 54 2986 2990.
34. Noguchi S, Aihara T, Nakamori S et al. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase- polymerase chain reaction. Cancer 1994 74 1595 1600.
35. Mori M, Mimori K, Inoue H et al. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res. 1995 55 3417 3420.
36. Mori M, Mimori K, Ueo H et al. Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas. J. Clin. Oncol. 1998 16 128 132.
37. Liefers GJ, Cleton-Jansen AM, van de Velde CJ et al. Micrometastases and survival in stage II colorectal cancer. N. Engl. J. Med. 1998 339 223 228.
38. Wlodzimierz R, Rutkowski P, Nowecki ZI, Kulik J, Nasierowska-Guttmejer A, Siedlecki JA. Detection of melanoma cells in the lymphatic drainage after lymph node dissection in melanoma patients by using two-marker reverse transcriptase-polymerase chain reaction assay. Ann. Surg. Oncol. 2004 11 988 997.
39. Leitzel K, Lieu B, Curley E et al. Detection of cancer cells in peripheral blood of breast cancer patients using reverse transcription- polymerase chain reaction for epidermal growth factor receptor. Clin. Cancer Res. 1998 4 3037 3043.
40. Zach O, Kasparu H, Krieger O, Hehenwarter W, Girschikofsky M, Lutz D. Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA. J. Clin. Oncol. 1999 17 2015 2019.
41. Blaheta HJ, Paul T, Sotlar K et al. Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness. Br. J. Dermatol. 2001 145 195 202.
42. Schoenfeld A, Kruger KH, Gomm J et al. The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19. Eur. J. Cancer 1997 33 854 861.
43. Gerhard M, Juhl H, Kalthoff H, Schreiber HW, Wagener C, Neumaier M. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J. Clin. Oncol. 1994 12 725 729.
44. Bostick PJ, Chatterjee S, Chi DD, Huynh TK, Giuliano AE, Cote R, Hoon DS. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J. Clin. Oncol. 1998 16 2632 2640.
45. Zippelius A, Kufer P, Honold G et al. Limitations of reverse- transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. J. Clin. Oncol. 1997 15 2701 2708.
46. Ko Y, Klinz M, Totzke G, Gouni-Berthold I, Sachinidis A, Vetter H. Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood. Clin. Cancer Res. 1998 4 2141 2146.
47. Inokuchi M, Ninomiya I, Tsugawa K, Terada I, Miwa K. Quantitative evaluation of metastases in axillary lymph nodes of breast cancer. Br. J. Cancer 2003 89 1750 1756.
48. Carter BA, Jensen RA, Simpson JF, Page DL. Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am. J. Clin. Pathol. 2000 113 259 265.
49. Abdul-Rasool S, Kidson SH, Panieri E, Dent D, Pillay K, Hanekom GS. An evaluation of molecular markers for improved detection of breast cancer metastases in sentinel nodes. J. Clin. Pathol. 2006 59 289 297.
50. Backus J, Laughlin T, Wang Y et al. Identification and characterization of optimal gene expression markers for detection of breast cancer metastasis. J. Mol. Diagn. 2005 7 327 336.
51. Blumencranz P, Whitworth PW, Deck K et al. Scientific Impact Recognition Award. Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors. Am. J. Surg. 2007 194 426 432.
52. Viale G, Dell'Orto P, Biasi MO et al. Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription- polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients. Ann. Surg. 2008 247 136 142.
53. Mansel RE, Goyal A, Douglas-Jones AG et al. Clinical Trial: detection of breast cancer metastasis in sentinel lymph nodes using intra-operative real time GeneSearch TM BLN Assay in the operating room: results of the Cardiff study. Breast Cancer Res. Treat. 2008 in press).
54. [E Pub ahead of print. DOI : RR, Weaver DL, Cserni G et al. Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based training. J. Clin. Oncol. 2008 26 258 263.